Literature DB >> 17318045

Endoscopic stenting for malignant gastric outlet obstruction.

Marek Stawowy1, Aksel Kruse, Frank V Mortensen, Peter Funch-Jensen.   

Abstract

BACKGROUND AND AIMS: Obstruction often gives rise to disabling symptoms in non curable malignant upper gastrointestinal disease. Surgical relief is associated with high morbidity and mortality. We report outcomes of 24 patients palliated with endoscopic inserted stents. PATIENTS STUDIED: Thirteen females and 11 males, median age 66 years (range 24 to 88) suffered from gastroduodenal obstruction because of non curable malignant disease. All patients had nausea, repeated vomiting, and weight loss. The obstruction was localized in the stomach (n=5), gastrojejunostomy (n=3), or the duodenum (n=16). Self-expanding metal stents were delivered endoscopically under fluoroscopic control.
RESULTS: All patients got an improved quality of life and could eat at least semisolid food. All the patients were followed until they died. The median survival time after the procedure was 6.4 (range 0.5 to 23) months. In 1 patient stenting was complicated by perforation leading to death 2 weeks later. In another patient the stent migrated during the initial placement, but a secondary stent could be placed during the same procedure. Due to a long duodenal stenosis 2 patients got 2 stents under the primary procedure. During the follow-up period, 6 patients had supplementary gastroduodenal stents placed. Nine patients had biliary stents placed before the placement of the gastroduodenal stents, 2 after.
CONCLUSIONS: Our data suggest that endoscopic stenting for disabling symptoms due to gastroduodenal obstruction from non curable malignant disease, gives good symptomatic improvement with only few complications.

Entities:  

Mesh:

Year:  2007        PMID: 17318045     DOI: 10.1097/SLE.0b013e31803125b8

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  6 in total

1.  Outcome for self-expandable metal stents in malignant gastroduodenal obstruction: single-center experience with 104 patients.

Authors:  Ilona Keränen; Marianne Udd; Anna Lepistö; Jorma Halttunen; Leena Kylänpää
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

2.  Palliation of malignant gastric outlet obstruction with simultaneous endoscopic insertion of afferent and efferent jejunal limb enteral stents in patients with recurrent malignancy.

Authors:  Isaac Soo; Hans Gerdes; Arnold J Markowitz; Robin B Mendelsohn; Emmy Ludwig; Pari Shah; Mark A Schattner
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

3.  Risk factors for morbidity and mortality following gastroenterostomy.

Authors:  Martin Poulsen; Mauro Trezza; Ghayyath H Atimash; Lars T Sorensen; Finn Kallehave; Ulla Hemmingsen; Lars N Jorgensen
Journal:  J Gastrointest Surg       Date:  2009-04-28       Impact factor: 3.452

4.  Enteral stenting for gastric outlet obstruction and afferent limb syndrome following pancreaticoduodenectomy.

Authors:  Wilson T Kwong; Syed M Fehmi; Andrew M Lowy; Thomas J Savides
Journal:  Ann Gastroenterol       Date:  2014

Review 5.  Treatment of malignant gastric outlet obstruction with stents: an evaluation of the reported variables for clinical outcome.

Authors:  Lene Larssen; Asle W Medhus; Truls Hauge
Journal:  BMC Gastroenterol       Date:  2009-06-17       Impact factor: 3.067

6.  Effects of the temporary placement of a self-expandable metallic stent in benign pyloric stenosis.

Authors:  Won Jae Choi; Jong-Jae Park; Jain Park; Eun-Hye Lim; Moon Kyung Joo; Jae-Won Yun; Hyejin Noh; Sung Ho Kim; Woo Seok Choi; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jae Seon Kim; Kwan Soo Byun; Young-Tae Bak
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.